The legionella pneumophila PilT homologue DotB exhibits ATPase activity that is critical for intracellular growth by Sexton, Jessica A. et al.




The legionella pneumophila PilT homologue DotB
exhibits ATPase activity that is critical for
intracellular growth
Jessica A. Sexton
Washington University School of Medicine in St. Louis
Jerome S. Pinkner
Washington University School of Medicine in St. Louis
Robyn Roth
Washington University School of Medicine in St. Louis
John E. Heuser
Washington University School of Medicine in St. Louis
Scott J. Hultgren
Washington University School of Medicine in St. Louis
See next page for additional authors
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Sexton, Jessica A.; Pinkner, Jerome S.; Roth, Robyn; Heuser, John E.; Hultgren, Scott J.; and Vogel, Joseph P., ,"The legionella




Jessica A. Sexton, Jerome S. Pinkner, Robyn Roth, John E. Heuser, Scott J. Hultgren, and Joseph P. Vogel
This open access publication is available at Digital Commons@Becker: http://digitalcommons.wustl.edu/open_access_pubs/2718
  
10.1128/JB.186.6.1658-1666.2004. 
2004, 186(6):1658. DOI:J. Bacteriol. 
Heuser, Scott J. Hultgren and Joseph P. Vogel
Jessica A. Sexton, Jerome S. Pinkner, Robyn Roth, John E.
 
That Is Critical for Intracellular Growth
Homologue DotB Exhibits ATPase Activity 
 PilTLegionella pneumophilaThe 
http://jb.asm.org/content/186/6/1658




This article cites 42 articles, 23 of which can be accessed free
CONTENT ALERTS
 more»articles cite this article), 
Receive: RSS Feeds, eTOCs, free email alerts (when new
http://journals.asm.org/site/misc/reprints.xhtmlInformation about commercial reprint orders: 
http://journals.asm.org/site/subscriptions/To subscribe to to another ASM Journal go to: 
 o
n
 April 22, 2014 by W








 April 22, 2014 by W






JOURNAL OF BACTERIOLOGY, Mar. 2004, p. 1658–1666 Vol. 186, No. 6
0021-9193/04/$08.000 DOI: 10.1128/JB.186.6.1658–1666.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
The Legionella pneumophila PilT Homologue DotB Exhibits ATPase
Activity That Is Critical for Intracellular Growth
Jessica A. Sexton,1 Jerome S. Pinkner,1 Robyn Roth,2 John E. Heuser,2 Scott J. Hultgren,1 and
Joseph P. Vogel1*
Department of Molecular Microbiology1 and Department of Cell Biology and Physiology,2 Washington
University, St. Louis, Missouri 63110
Received 16 September 2003/Accepted 25 November 2003
The ability of Legionella pneumophila to grow and cause disease in the host is completely dependent on a type
IV secretion system known as the Dot/Icm complex. This membrane-spanning apparatus translocates effector
molecules into host cells in a process that is poorly understood but that is known to require the putative
ATPase DotB. One possible role for DotB is suggested by its similarity to the PilT family of proteins, which
mediate pilus retraction. To better understand the molecular behavior of DotB, we have purified the protein
and shown that it forms stable homohexameric rings and hydrolyzes ATP with a specific activity of 6.4 nmol
of ATP/min/mg of protein. ATPase activity is critical to the function of DotB, as alteration of the conserved
Walker box lysine residue resulted in a mutant protein, DotB K162Q, which failed to bind or hydrolyze ATP
and which could not complement a dotB strain for intracellular growth in macrophages. Consistent with the
ability of DotB to interact with itself, the dotBK162Q allele exhibited transdominance over wild-type dotB,
providing the first example of such a mutation in L. pneumophila. Finally, the DotB K162Q mutant protein had
a significantly enhanced membrane localization in L. pneumophila compared to wild-type DotB, suggesting a
relationship between nucleotide binding and membrane association. These results are consistent with a model
in which DotB cycles between the cytoplasm and the Dot/Icm complex at the membrane, where it hydrolyzes
nucleotides to provide energy to the complex.
Legionella pneumophila, an intracellular bacterial pathogen,
causes Legionnaires’ disease by replicating inside alveolar
macrophages (13). This ability is dependent on a set of genes
called dot or icm, which encode a specialized type IV secretion
system (32, 37). The type IV secretion system family is com-
posed of both classical plasmid transfer systems and a related
protein export apparatus used by a wide range of pathogens to
export toxins (reviewed in reference 4). For L. pneumophila,
the Dot/Icm complex is believed to translocate numerous ef-
fector molecules into host cells in order to modify the endo-
cytic pathway. Thus far, two translocated proteins, LidA and
RalF, have been identified (6, 19). RalF is an ADP-ribosylating
factor that functions to recruit the macrophage protein ARF1
to L. pneumophila-containing phagosomes, while the function
of LidA remains unknown. Because neither of these is abso-
lutely required for L. pneumophila intracellular growth, addi-
tional Dot/Icm-secreted proteins are believed to exist (6).
The Dot/Icm apparatus is a macromolecular complex that
comprises a large number of membrane proteins and several
proteins predicted to have cytoplasmic localization. One such
cytoplasmic protein, DotB, contains conserved nucleotide
binding domains present in many ATPases, as well as domains
specific to ATPases found in bacterial type II and type IV
secretion systems (23, 27, 39). Though DotB is known to be a
critical component of the Dot/Icm complex (37, 38), its molec-
ular function is not yet clear. BLAST searches reveal that
DotB is most similar to several uncharacterized putative
ATPases found in other type IVB secretion systems including
a Coxiella burnetii DotB homologue (BLAST score, e135) and
the TraJ protein of plasmid R64 (BLAST score, e41). DotB
also has limited similarity to the type IVA secretion ATPases
HP0525 of Helicobacter pylori (BLAST score, e4) and VirB11
of Agrobacterium tumefaciens (BLAST score, e2). Finally,
DotB has extensive similarity to the PilT family of proteins
(BLAST score, e38) found in bacterial type II secretion sys-
tems. PilT proteins are ATPases that mediate the retraction of
adhesive pili, a process essential to bacterial twitching motility
and natural transformation (10, 18, 34).
Since PilT proteins are components of type II secretion
systems, which are evolutionarily quite divergent from type IV
secretion systems (22), the similarity between DotB and PilT is
surprising. Pilus retraction is well documented both in type II
secretion systems (e.g., type IV pili) and in the conjugal type
IV secretion systems (20). However, in the latter case, the
mechanism of this retraction is completely unknown; no pilus
retraction factors or PilT-like proteins have yet been identified.
Now, L. pneumophila, C. burnetii, and plasmid R64 DNA se-
quences have revealed the existence of three PilT homologues
in the type IVB secretion systems. Whether these proteins
function as the type IVA secretion ATPases are thought to, as
assembly and export chaperones for their respective secretion
complexes (14–16), or whether they might mediate retraction
of pili elaborated by type IV secretion complexes remains to be
determined.
The families of type II and type IV secretion ATPases per-
form a wide range of functions including assembly of trans-
membrane complexes, pilus assembly, pilus retraction, and
* Corresponding author. Mailing address: Washington University
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substrate export (3, 10, 14, 15, 28, 29, 36). Remarkably, despite
their diverse functions, biochemical characterization of a num-
ber of these proteins has revealed that they possess a unifying
set of phenotypes. First, in addition to the Walker A and B
boxes, these proteins contain conserved domains that cluster
them together as a superfamily (23, 27, 39). Second, they ex-
hibit ATPase activity in vitro which is essential to their function
(3, 5, 10, 15, 27, 29, 35). Third, they multimerize and most are
known to form homohexameric rings (3, 14, 15, 24, 26, 27, 36).
Fourth, all are predicted to be hydrophilic but those localized
can be found in both the cytoplasm and the membrane frac-
tions of the bacterial cells (3, 10, 25, 27, 30). Finally, several of
these purified proteins exhibit increased ATPase activity in the
presence of phospholipids, suggesting that the bacterial mem-
brane is the site of their enzymatic activity (3, 15, 27).
To determine the molecular function of the putative ATPase
and PilT homologue DotB, we have chosen to purify the pro-
tein and examine it biochemically. ATPase activity, multimeric
state, and membrane localization have all been addressed. In
addition, a mutant form of the protein was engineered and
characterized with the goal of understanding the importance of
DotB ATPase activity to its function in L. pneumophila patho-
genesis.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. Bacterial strains are listed in Table 1.
Strain Lp02 (thyA hsdR rpsL) is a derivative of the L. pneumophila serogroup 1
clinical isolate Philadelphia-1 (2). All L. pneumophila strains were cultured on
ACES [N-(2-acetamido)-2-aminoethanesulfonic acid]-buffered charcoal yeast
extract agar (CYE) or in ACES-buffered yeast extract broth (AYE) as described
previously (7, 9). Lp02 and Lp02 derivatives were cultured on CYE or AYE
supplemented with 100 g of thymidine/ml as needed. Escherichia coli strains
C600 and XL1-Blue were cultured in Luria-Bertani broth containing ampicillin
at 100 g/ml for maintenance of plasmid selection.
Strain and plasmid construction. The suicide plasmid pJB920, used to create
the dotB strain JV918, was constructed by PCR amplification of 500-bp regions
flanking the dotB open reading frame (ORF) from Lp02 chromosomal DNA with
primers engineered to have SalI, BamHI, or EagI restriction sites. The resulting
fragments were cut with SalI/BamHI or BamHI/EagI, cloned in a three-piece
ligation into the SalI/NotI sites of the suicide vector pSR47S (17), and confirmed
by sequencing. Next, pJB920 was transformed into Lp02, where it integrated via
homologous recombination into the chromosome, generating a dotB/dotB
merodiploid. The merodiploid was resolved by counterselection based on sucrose
sensitivity, and the resulting colonies were screened for the absence of dotB via
PCR, thus generating strain JV918.
The suicide plasmid pJB2911, used to create the Flag-DotB strain JV3079, was
constructed as follows. Regions of 500 bp immediately upstream and down-
stream of the dotB start codon were amplified by PCR from Lp02 chromosomal
DNA with primers engineered to have SalI, BamHI, or EagI restriction sites. The
resulting fragments were cut with SalI/BamHI or BamHI/EagI, cloned in a
three-piece ligation into the SalI/NotI sites of the suicide vector pSR47S (17),
and confirmed by sequencing. Next, oligonucleotides encoding the Flag epitope
(DYKDDDDK) were inserted into the BamHI site engineered immediately
following the dotB start codon, resulting in destruction of the site. Finally, this
suicide plasmid (pJB2911) was transformed into Lp02 to generate a dotB/Flag-
dotB merodiploid, which was then resolved. Colonies were screened by Western
blotting for the presence of Flag-DotB, and strain JV3079, which contains only
Flag-DotB, was generated.
The cloning vector pJB908, a derivative of the RSF1010 vector pKB5 (2), was
used to create dotB and dotBK162Q complementing clones. To make pJB908, the
pKB5 origin of conjugative transfer (oriT), contained on an SfiI/BstZ17I frag-
ment, was replaced with an SfiI/BstZ17I fragment with oriT deleted (8). To make
the plasmid pJB1153, which encodes the wild-type DotB protein, the dotB ORF
was amplified by PCR from Lp02 chromosomal DNA with primers containing
BamHI or SalI restriction sites at their 5 prime ends. The resulting PCR product
was digested with BamHI and SalI, cloned into the BamHI/SalI sites of pJB908,
and confirmed by sequencing. To make the plasmid pJB1568, which encodes the
Walker box mutant protein DotB K162Q, the 5 prime and 3 prime portions of
the dotB ORF were amplified separately. Each primer described above was
paired with one of two overlapping divergent primers engineered to replace
TABLE 1. Bacterial strains and plasmids
Strain or plasmid Relevant properties Referenceor source
L. pneumophila
Philadelphia-1 Clinical isolate, serogroup 1 CDCa
Lp02 Philadelphia-1 SmR, r thyA 2
JV918 Lp02 dotB This study
JV3079 Lp02 dotB::Flag coding sequence fused to dotB This study
E. coli
C600 e14(McrA) supE44 thi-1 thr-1 leuB6 lacY1 tonA21 Stratagene




pQE30 Expression vector for His-tagged proteins (Ampr) Qiagen
pJB1540 pQE30 with thrombin site This study
pJB1572 pJB1540 with dotB This study
pJB2442 pJB1540 with dotBK162Q This study
pJB908 RSF1010 cloning vector (Ampr tdi) This study
pJB1153 pJB908 with dotB This study
pJB1568 pJB908 with dotBK162Q This study
pJB1192 pJB908 with His coding sequence fused to dotB This study
pJB2444 pJB908 with His coding sequence fused to dotBK162Q This study
pSR47S R6K suicide vector (Kanr sacB) 17
pJB920 pSR47S with dotB flanking regions This study
pJB2911 pSR47S with Flag coding sequence fused to dotB This study
a CDC, Centers for Disease Control and Prevention (Atlanta, Ga.).
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DotB lysine 162 with a glutamine. These primers were designed by using the
Primer Generator program (http://www.med.jhu.edu/medcenter/primer/primer
.cgi) and resulted in PCR products with altered dotB sequences, creating the
K162Q mutation as well as a novel AvaI site. 5 and 3 PCR products were
digested with BamHI and AvaI or AvaI and SalI, cloned in a three-piece ligation
into the BamHI/SalI sites of pJB908, and confirmed by sequencing. Primers were
as follows: dotB, 5CCCGGATCCAGTAAGTTAATGTCTATGG and 3CCCG
TCGACGATTATTGTTGATATTCTTTGG (boldface letters indicate start or
stop codons, and restriction sites are underlined); K162Q (dotB internal), 5CC
CCTCGGGCCAATCGACATTGTTAGCTTCC and 3CCCGGCCCGAGCCG
GTAGCGCCTGTAATAAAC (boldface letters indicate bases that differ from
the dotB sequence, and restriction sites are underlined).
The expression vectors for His-tagged versions of DotB and DotB K162Q that
were used for protein purification were engineered with plasmid pJB1540, a
derivative of the Qiagen (Valencia, Calif.) expression vector pQE30. Plasmid
pJB1540 encodes a thrombin cleavage site downstream of the sequence encoding
the six-His tag and was constructed by cloning overlapping oligonucleotides
containing a thrombin cleavage site and BamHI cohesive ends into the BamHI
site of pQE30, destroying the upstream BamHI site. The wild-type dotB and
dotBK162Q ORFs (minus the ATG start codons) were amplified by PCR from
pJB1153 or pJB1568 plasmid DNA with primers containing BamHI or SalI
restriction sites at their 5 prime ends. The resulting PCR product was digested
with BamHI and SalI, cloned into the BamHI/SalI sites of pJB1540, and con-
firmed by sequencing. This resulted in the constructs pJB1572 (wt) and pJB2442
(K162Q mutant). Coding sequences for His-tagged versions of wild-type and
mutant DotB were subcloned from pJB1572 and pJB2442 into the RSF1010
vector pJB908 for expression in L. pneumophila. These constructs were desig-
nated pJB1192 and pJB2444, respectively.
Intracellular growth assays. The human monocytic cell line U937 was pas-
saged, and cells were differentiated with phorbol 12-myristate 13-acetate (Sigma)
as described previously (21). L. pneumophila strains to be used for infection of
U937 cells were grown to exponential phase, back-diluted into media containing
1 mM isopropyl--D-thiogalactopyranoside (IPTG) for overexpression of dotB,
and then grown to early stationary phase. Approximately 109 bacteria were
pelleted, washed one time in sterile deionized water, resuspended in 1 ml of
sterile deionized water, and then diluted 1:4,000 into RPMI 1640 (BioWhittaker)
tissue culture medium. This suspension (0.5 ml) was added to a monolayer of
differentiated U937 cells (106 per well) in 24-well dishes, and the mixture was
coincubated for 1 h at 37°C in 5% CO2. Medium containing extracellular bacteria
was then aspirated, and the U937 cell monolayer was washed two times with 0.5
ml of RPMI 1640 containing 1 mM IPTG. Cell monolayers were maintained at
37°C in 5% CO2 for 3 days, and each day bacteria were recovered and plated to
determine total CFU in a given well. Because L. pneumophila cannot replicate in
RPMI 1640, daily quantitation of CFU allows an accurate representation of
bacterial intracellular growth over time.
Antibody generation and affinity purification. Purified His-DotB was injected
into rabbits (Cocalico, Inc.) for generation of a polyclonal DotB antibody, which
was subsequently affinity purified as follows. Purified His-DotB (2 mg) was
separated via sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred to a polyvinylidene fluoride membrane (Millipore), and
the His-DotB protein band was cut away from the rest of the membrane. The
resulting membrane strip was incubated with 1.5 ml of polyclonal serum diluted
in BLOTTO (phosphate-buffered saline [PBS], 5% nonfat dry milk) for 3 h at
room temperature, washed in PBS, and incubated with 8 ml of 0.2 M glycine (pH
2.8) for 2 min in order to elute antibody from the membrane. Glycine was
neutralized by addition of 2 ml of 1 M Tris (pH 8.8), purified antibody was
removed, and a second round of elution was performed. Pooled purified anti-
body was then concentrated with Ultrafree 15 filter columns with a 10-kDa
molecular weight cutoff (Millipore), and buffer was exchanged with PD-10 col-
umns (Amersham Biosciences) into PBS containing 0.02% sodium azide and
bovine serum albumin (BSA) at 1 mg/ml.
Electron microscopy. Proteins were diluted to 16 g/ml in cold KHMgE buffer
(70 mM KCl, 30 mM HEPES [pH 7.4], 1 mM MgCl2, 3 mM EGTA) with or
without nucleotides (1 mM) and processed according to published protocols (11,
12). Platinum replicas were viewed in a JEOL transmission electron microscope
and photographed in stereo. Micrographs (68,000) were digitized by video
imaging and were transferred to a computer.
Membrane fractionation. Bacterial cells (100 OD600 [optical density at 600
nm] units) were grown to late stationary phase, harvested, and stored at 20°C
until needed. For preparation of membrane fractions, cells were resuspended in
1 ml of cold Tris-sucrose (50 mM Tris [pH 8.0], 500 mM sucrose, 5 mM EDTA);
lysozyme was added to 100 g/ml, and cells were incubated on ice for 1 h to
create spheroplasts. These were then pelleted at 5,000  g (4°C), resuspended in
2.5 ml of cold 20 mM Tris (pH 8.0), and lysed by sonication. Lysate was cleared
by 10 min of centrifugation at 10,000  g and 4°C. Lysate (the total protein
fraction) was then subjected to ultracentrifugation for 1 h at 100,000  g and 4°C
to pellet the membrane fractions. The membrane pellet was washed in cold 20
mM Tris (pH 8.0) and then repelleted for 30 min at 100,000  g (4°C) and
resuspended. This fraction represented the total membrane.
Protein purification. C600 cells containing plasmid pJB1572 were grown in 5
liters of Luria-Bertani broth at 37°C. Cells were induced in mid-log phase to
express DotB by adding 200 M IPTG to the medium and were grown to
stationary phase (OD600, 5) before harvesting. A cell pellet of approximately
80 g was obtained and was resuspended in 150 ml of cold buffer A (20 mM Tris
[pH 7.6], 100 mM NaCl, 10% glycerol, 0.01% Brij 35) with 10 mM imidazole;
lysozyme was added to 1 mg/ml, cells were incubated for 30 min on ice and lysed
by sonication on ice, and lysate was cleared by 40 min of centrifugation at 20,000
 g and 4°C. Lysate was split into 50-ml screw-cap conical tubes (nine tubes, 40
ml/tube), and 0.5 ml of nickel-nitrilotriacetic acid–agarose (Ni-NTA–agarose)
(Qiagen) was added to each. Tubes were incubated, with mixing, for 2 h at 4°C.
Three columns (1.5 by 12 cm; Bio-Rad) were packed with the loaded resin. Each
column was washed stepwise via gravity flow with cold buffer A containing 10 and
30 mM imidazole, and protein was eluted off the resin in cold buffer A with 100
mM imidazole. Elution fractions were pooled, total protein content was deter-
mined by the Bio-Rad protein assay (based on the method of Bradford), and
thrombin was added at 16 g per mg (estimated) of His-DotB in order to remove
the N-terminal tag. The cleavage reaction was allowed to proceed for 2 h at 25°C.
Proteins were then applied to an 8-ml Source 15Q (Amersham Biosciences)
ion-exchange column equilibrated in buffer A; this and subsequent steps in DotB
purification were performed with AKTA Explorer fast protein liquid chroma-
tography equipment by Pharmacia. Proteins were eluted with an 80-ml linear
gradient from 100 to 500 mM NaCl in buffer A. DotB eluted at 230 mM NaCl.
Fractions containing DotB were pooled, and buffer was exchanged with a PD-10
column (Amersham Biosciences) into buffer B (20 mM KPO4, 50 mM KCl, 10%
glycerol, 1 mM dithiothreitol [DTT]) and applied to a 3-ml hydroxyapatite
(Bio-Rad) column equilibrated in buffer B. Proteins were eluted with a 45-ml
linear gradient from 20 to 220 mM KPO4 and 0 to 500 mM NaCl in buffer B.
DotB eluted at approximately 350 mM KPO4-150 mM NaCl. Fractions contain-
ing DotB were pooled, protein was exchanged into buffer D (buffer A plus 1 mM
DTT and 0.1 mM EDTA), and the sample was concentrated to a final volume of
400 l with Ultrafree 4 filter columns with a 10-kDa molecular mass cutoff
(Millipore). Concentrated DotB was then applied in a single injection to a 25-ml
Superose 12 column (Amersham Biosciences) equilibrated in buffer D. DotB
eluted in single peak at a total elution volume of 9.8 ml. Fractions containing
DotB were pooled and brought to a final concentration of 2 mg/ml. This proce-
dure yielded, on average, 3 to 4 mg of highly purified DotB (quantitated 97%
pure; AlphaImager software). Purification of DotB K162Q (expressed in C600
with pJB2442) was performed in exactly the same fashion, and preparations were
equally pure.
ATPase and ATP binding assays. ATP hydrolysis reactions were performed
with the EnzChek phosphate assay kit (Molecular Probes). Each reaction mix-
ture contained 3 to 24 M purified protein (molarity was calculated for mono-
meric DotB) in buffer D with 1 mM ATP, 10 mM MgCl2, 4 mM EnzChek
substrate (2-amino-6-mercapto-7-methylpurine riboside [MESG]), and 0.1 U of
EnzChek enzyme (purine nucleoside phosphorylase [PNP]). In the presence of
inorganic phosphate MESG is converted via PNP to ribose 1-phosphate and
2-amino-6-mercapto-7-methylpurine. This results in an absorbance shift from
330 to 360 nm, thus creating a spectrophotometric readout for the concentration
of inorganic phosphate in each reaction. Reactions were performed in 100-l
volumes in 96-well plates and were allowed to proceed for 30 min at 25°C, at
which point the A360 was determined with a VERSAmax plate reader (Molecular
Devices). Total phosphate concentrations were determined by comparing sample
absorbances to those of a phosphate standard curve.
For ATP binding reactions, 20 g of purified protein was mock preincubated
or preincubated with 10 mM ATP for 1 h at 4°C and then added to 400-l
reaction mixtures containing 20 mM MES (morpholineethanesulfonic acid; pH
7.0), 40 l of ATP- or AMP-agarose (Sigma), and 100 g of BSA (Sigma).
Samples were incubated at 4°C for 90 min with mixing, and nucleotide-agarose
was then pelleted by centrifugation and washed three times with 400 l of cold
20 mM MES (pH 7.0). Bound proteins were eluted by addition of 40 l of
SDS-PAGE sample buffer and 5 min of boiling and then separated by SDS-
PAGE for Coomassie staining and visualization. Alternatively, 40 l of ATP- or
AMP-agarose was added to 500 l of L. pneumophila lysate in buffer E (50 mM
Tris [pH 8.0], 150 mM NaCl, 1% Triton X-100) from 3 OD600 equivalents of L.
pneumophila cells. Competing ATP was added to a final concentration of 10 mM.
Reaction mixtures were incubated at 4°C for 6 h with mixing, and nucleotide-
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agarose was pelleted by centrifugation and washed three times with 500 l of
cold buffer E. Bound proteins were eluted by addition of 50 l of SDS-PAGE
sample buffer and 5 min of boiling, separated by SDS-PAGE, and transferred to
a polyvinylidene fluoride membrane for analysis by Western blotting.
RESULTS
The K162 residue is essential to DotB function. To deter-
mine whether the predicted ATPase activity of DotB might be
important for its function, a mutation in the DotB Walker A
box was engineered, changing the highly conserved lysine to a
glutamine. When the DotB K162Q mutant protein was ex-
pressed from the Ptac promoter in the L. pneumophila dotB
deletion strain JV918, intracellular growth was identical to that
of the dotB deletion strain containing the empty expression
vector, indicating that the Walker box mutant was not able to
function in L. pneumophila (Fig. 1A). One possibility was that
the DotB K162Q protein was not stable, despite the fact that a
lysine-to-glutamine change should be structurally conservative.
To test this, bacterial cells used for U937 infections were sub-
jected to analysis by Western blotting with affinity-purified
DotB antibody. Though apparently not as stable as wild-type
DotB (Fig. 1B, compare lanes 6 and 5), DotB K162Q was
found to be present in greater abundance than chromosomally
encoded DotB in the wild-type strain Lp02 (Fig. 1B, compare
lanes 6 and 1). Based on this observation, we concluded that
the lack of functionality of DotB K162Q could not be attrib-
uted to an insufficient amount of protein.
In addition to being nonfunctional in a dotB strain, DotB
K162Q was found to inhibit the intracellular growth of the
wild-type L. pneumophila strain Lp02 about 100-fold (Fig. 1A).
This inhibition was not simply due to the increased level of
DotB protein in the cells, as the overexpression of wild-type
DotB did not affect Lp02 intracellular multiplication (Fig. 1A).
Therefore, the Walker box mutant protein is not functional on
its own and the mutation, when expressed in high copy num-
ber, is dominant negative in nature.
DotB is an ATPase. Based on the presence of several con-
served nucleotide binding and hydrolysis domains within DotB
sequence and on the requirement of the DotB Walker A box
residue K162 for function (Fig. 1A), we predicted the DotB
protein would exhibit ATP-hydrolyzing activity. To test this
prediction, we engineered an N-terminal hexahistidine fusion
that was expressed in E. coli and purified by Ni2 affinity,
ion-exchange, hydroxyapatite, and gel filtration chromatogra-
phy (Fig. 2A). Targeted protease digestion was used to remove
the His tag (Fig. 2A, compare lanes 3 and 4), leaving G-S-DotB
(a glycine and a serine fused to DotB amino acid residues 2 to
377). The major protein band (42 kDa) was recognized by a
FIG. 1. Complementation of a dotB mutant for intracellular growth
and transdominance of DotB K162Q in wild-type L. pneumophila.
(A) Intracellular growth in U937 monocytes. L. pneumophila dotB
strain JV918 containing empty vector pJB908 (triangles), the DotB
complementing clone pJB1153 (hatched squares), and the DotB
K162Q clone pJB1568 (diamonds) was assayed for growth in U937
cells over time. In addition, L. pneumophila wild-type strain Lp02
containing empty vector pJB908 (open squares), the DotB comple-
menting clone pJB1153 (open diamonds), and the DotB K162Q clone
pJB1568 (circles) was also assayed for growth in U937 cells. (B) Strains
used in panel A were examined by Western blotting for relative DotB
levels at the time of infection. Lane 1, Lp02(pJB908); lane 2,
Lp02(pJB1153); lane 3, Lp02(pJB1568); lane 4, JV918(pJB908); lane
5, JV918 (pJB1153); lane 6, JV918(pJB1568). The molecular masses of
relevant markers (in kilodaltons) are on the left. Large arrowhead,
DotB or DotB K162Q band; small arrowhead, cross-reacting band that
serves to confirm overall sample equivalence.
FIG. 2. Purification of DotB and DotB K162Q from E. coli.
(A) Coomassie-stained SDS-PAGE gel showing wild-type DotB puri-
fication steps. Lane 1, cell extract from E. coli C600 containing plasmid
pJB1572, no induction; lane 2, cell extract from C600(pJB1572), IPTG
induced; lane 3, eluate from Ni-NTA–agarose after incubation with
His-DotB lysate; lane 4, Ni-NTA eluate after exposure to thrombin;
lane 5, purified DotB after three additional separation procedures.
(B) Coomassie-stained SDS-PAGE gel showing DotB K162Q purifi-
cation steps. Lanes are as for panel A, except that DotB K162Q was
expressed with C600(pJB2442). (A and B) Small arrowhead, His-DotB
or His-DotB K162Q bands; large arrowhead, bands representing DotB
or DotB K162Q with the His tags removed. Standards of known mo-
lecular masses (kilodaltons) are on the left.
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polyclonal DotB antibody (data not shown). On average, 5-li-
ter cultures yielded 3 to 4 mg of purified DotB, and the protein
preparation was estimated to be approximately 97% pure.
To assay ATPase activity of DotB, we employed a colori-
metric assay that measures the presence of inorganic phos-
phate in solution (EnzChek; Molecular Probes). When free
phosphate is present, it is used as a reagent in a chemical
reaction that generates a product with maximum absorbance at
360 nm. Thus, the liberation of Pi by an ATPase, such as our
positive control apyrase, can be quantitated by comparing A360
to that of a phosphate standard curve. When this simple end
point assay was performed, increasing amounts of apyrase cor-
responded to increased A360 readings, indicating that the en-
zyme hydrolyzed ATP in proportion to its concentration (Fig.
3B). Positive readings were absolutely dependent on the addi-
tion of ATP to the reaction and on the presence of apyrase
(data not shown), indicating that the source of Pi was enzy-
matically hydrolyzed nucleotides.
Likewise, purified DotB liberated Pi from ATP in a concen-
tration-dependent fashion, though to a lesser extent than the
very active ATPase apyrase (Fig. 3C). DotB-specific activity
was calculated to be 6.4 nmol of ATP/min/mg of protein, while
that of apyrase was found to be 3.0 mol/min/mg. Because the
activity of DotB was quite low, we needed to demonstrate that
it was due to the presence of DotB rather than a contaminating
ATPase that might be present in the preparation in trace
amounts. To eliminate this possibility, we employed the non-
functional DotB K162Q mutant protein, which was predicted
to lack enzymatic activity. DotB K162Q was purified in exactly
the same fashion as the wild-type protein (Fig. 2B) and was
tested by the EnzChek assay. The mutant protein did not
generate detectable levels of Pi, indicating that it is enzymati-
cally null (Fig. 3C) and that the activity seen for the wild-type
protein is bona fide.
DotB is a hexameric ring. The discovery that several type
IVA ATPases exist as homohexameric rings has inspired a
model of function wherein the central chamber is the site of
potential chaperone activity that is required for translocation
and assembly of secretion complex components (14–16, 40).
Initial experiments using native PAGE suggested that purified
DotB could be found only in a hexameric state (data not
shown). To more precisely determine DotB molecular mass,
we subjected purified DotB to gel filtration analysis. The pro-
tein was found to have a native molecular mass of 259 kDa,
a value consistent with the predicted molecular mass of a
hexamer (252 kDa) (Fig. 4). In addition, the gel filtration
elution profile for DotB K162Q was identical to that of wild-
type DotB, suggesting that it also can form a hexamer (data not
shown).
Next, we employed quick-freeze, deep-etch electron micros-
copy (11, 12), one of the most sensitive and accurate tech-
niques available for visual examination of proteins, to observe
the conformation of DotB. Purified protein was diluted in
KHMgE buffer and incubated with no nucleotides, with ADP,
or with ATP	S and then prepared and visualized with platinum
replicas as described in Materials and Methods. Wild-type
DotB appeared to exist solely and uniformly as rings of 10
nm in diameter, each with an electron-dense center that may
represent a completely open hole—as in a doughnut shape—or
perhaps the hollow chamber of a bowl-shaped molecule (Fig.
5A). Frequently, these rings were closely juxtaposed, even
sometimes appearing to be linked. The protein was found in
the same ring conformation regardless of the presence of nu-
cleotides, confirming that nucleotide binding is not needed for
hexamerization (Fig. 5B and C). Although changes in individ-
ual protein molecules were not discernible, the DotB sample
containing ATP	S appeared to contain an increased number
of linked rings (data not shown), reminiscent of tube-like struc-
tures observed for R388 TrwD (15). A preparation of purified
DotB K162Q was also subjected to analysis, with the prediction
that its loss of ability to hydrolyze nucleotides might be related
to an altered conformation. However the mutant protein, like
the wild type, appeared as 10-nm rings and was not affected
by the presence of nucleotides (Fig. 5D and data not shown).
DotB K162Q forms mixed multimers with wild-type DotB.
The observation that the dotBK162Q mutation is transdomi-
nant suggests that the mutant protein may exert this effect via
formation of nonfunctional mixed multimers. To investigate
FIG. 3. ATPase activity of purified DotB. ATPase activity was determined by measuring the amount of free phosphate in the reaction by a
colorimetric assay (EnzChek; Molecular Probes). (A) Standard curve showing absorbance at 360 nm as a function of the concentration of
phosphate. (B) ATPase activity of the positive control apyrase. (C) ATPase activity of DotB (squares) and DotB K162Q (diamonds). The specific
activities of apyrase and DotB were calculated to be 3.0 mol/min/mg and 6.4 nmol/min/mg, respectively. Each point represents three replicates.
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this possibility, the capacity of the DotB K162Q mutant protein
to multimerize with wild-type DotB was assayed by using a
strain containing two different versions of epitope-tagged
DotB. Wild-type DotB with an N-terminal Flag tag was ex-
pressed from the L. pneumophila chromosome, while DotB
K162Q with an N-terminal His tag was expressed from a plas-
mid. Both fusion proteins were confirmed to be functional by
intracellular growth assays (data not shown). Cell lysates of
strains containing Flag-DotB and empty vector, Flag-DotB and
the His-DotB complementing clone, or Flag-DotB and the
His-DotB K162Q clone were made and passed over Ni-NTA–
agarose. As expected, Flag-DotB in the absence of His-DotB
did not bind to the Ni2 matrix and was present in the
flowthrough fraction rather than the elution fraction (Fig. 6,
compare lanes 2 and 3). However, when Flag-DotB was in the
presence of His-DotB, it appeared in the Ni-NTA–agarose
elution fractions (Fig. 6, compare lanes 5 and 6), indicating an
interaction between Flag- and His-tagged wild-type DotB.
Moreover, the same result was obtained when Flag-DotB was
in the presence of His-DotB K162Q (Fig. 6, compare lanes 8
and 9). The elution fraction containing Flag-DotB and His-
FIG. 4. DotB is a hexamer. (A) Superose 12 elution profile for
purified wild-type DotB. Milli-absorbance units (mAU) are shown as a
function of elution volume. DotB eluted as a single peak correspond-
ing to a molecular mass of 259 kDa. Arrows show elution peaks for
standards of known molecular masses (Amersham Biosciences): 1,
thyroglobulin (669 kDa); 2, ferritin (440 kDa); 3, catalase (232 kDa);
4, aldolase (158 kDa); 5, BSA (67 kDa). (B) Coomassie-stained SDS-
PAGE gel demonstrating that the quantities of DotB in elution frac-
tions (Fxns) 7 to 15 correlate with the single protein elution peak. The
elution profile is representative of three experiments and is identical to
that for DotB K162Q (data not shown).
FIG. 5. Purified DotB and DotB K162Q proteins form hexameric rings 10 nm in diameter. (A to C) Wild-type DotB was visualized in the
absence of added nucleotides (A), revealing the putative apo form, as well as in the presence of 1 mM ADP (B) or 1 mM ATP	S (C). (D) DotB
K162Q was also visualized in the putative apoprotein (shown here) and nucleotide-bound (not shown) forms. Scale bar, 50 nm. Images are
representative of several thousand molecules visualized for each condition.
FIG. 6. Detection of mixed DotB/DotB K162Q multimers. Lysate
from L. pneumophila Flag-DotB strain JV3079 containing one of three
plasmids was subjected to Ni-NTA–agarose. Strains were JV3079 with
empty vector pJB908 (lanes 1 to 3), JV3079 with the His-DotB com-
plementing clone pJB1192 (lanes 4 to 6), and JV3079 with the His-
DotB K162Q clone pJB2444 (lanes 7 to 9). For each strain, three
samples were taken: total protein (lanes 1, 4, and 7), Ni-NTA–agarose
flowthrough (lanes 2, 5, and 8), and Ni-NTA–agarose eluate (lanes 3,
6, and 9). Samples were separated via SDS-PAGE, blotted onto a
polyvinylidene fluoride membrane, and used in a Flag Western blot to
detect the presence of Flag-DotB. The molecular masses of relevant
markers (in kilodaltons) are on the left.
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DotB K162Q was further subjected to gel filtration and West-
ern blot analysis to confirm the presence of both proteins in
hexameric multimers (data not shown). Thus, the Walker box
mutant protein DotB K162Q can interact with wild-type DotB
to form mixed hexamers.
DotB K162Q shows enhanced membrane localization spe-
cific to L. pneumophila. Though the DotB protein lacks any
obvious hydrophobic regions and therefore does not appear to
have membrane-spanning domains, there is a detectable
amount of DotB in L. pneumophila membrane fractions (Fig.
7A, lane 5). This is consistent with observations of numerous
secretion ATPases from type II and type IV systems, which
partition to various degrees to the cytoplasmic and membrane
fractions (10, 25, 27, 29, 30). Interestingly, a Walker A box
mutant version of the A. tumefaciens VirB11 protein, VirB11
K175A, displays significantly enhanced membrane association
relative to wild-type VirB11 (25). To examine the possibility
that DotB K162Q might exhibit an altered localization profile,
we prepared cell fractions from the L. pneumophila dotB
strain JV918 containing either empty vector, the wild-type
DotB complementing clone, or the DotB K162Q clone and
compared them by Western blotting to determine DotB and
DotB K162Q localization.
It appeared that a significant portion of the Walker box
mutant protein was associated with L. pneumophila mem-
branes. While soluble protein fractions (whole-cell lysate) con-
tained less total DotB K162Q than wild-type DotB (Fig. 7A,
lane 3 versus 2), indicating a relative lack of DotB K162Q
stability, fractions composed of only membrane proteins con-
tained more DotB K162Q than wild-type DotB (Fig. 7A, lane
6 versus 5). Analysis of serially diluted cell fractions allowed an
estimation that, while approximately 5% of wild-type DotB was
membrane associated, 40% of the Walker box mutant protein
DotB K162Q was present in the membrane fraction (data not
shown). Importantly, when this same experiment was repeated
using E. coli as a host strain, equivalent amounts of DotB and
DotB K162Q were localized to the membrane fractions (Fig.
7B, compare lanes 3 and 4). Thus, the enhanced membrane
localization of the DotB K162Q protein is a Legionella-specific
phenomenon and may indicate the presence of a specific re-
ceptor for DotB in the L. pneumophila inner membrane.
DotB K162Q cannot bind nucleotides. In search of an ex-
planation for the enhanced membrane affinity of DotB K162Q,
we wondered whether its association with the membrane might
be affected by its capacity to bind nucleotides. To examine this
ability, we took two approaches, exposing either purified pro-
tein or L. pneumophila whole-cell lysate to ATP- or AMP-
agarose beads (Sigma). The beads were washed, and the eluate
was analyzed via Coomassie-stained protein gels (Fig. 8A) or
DotB Western blotting (Fig. 8B and C). Purified wild-type
protein was present in the ATP-agarose eluate and was not
FIG. 7. Subcellular localization of DotB and DotB K162Q. (A) To-
tal protein (lanes 1 to 3) and total membrane protein (lanes 4 to 6)
fractions were taken from three L. pneumophila strains and were
subjected to DotB Western blotting. Strains included the dotB strain
JV918 with empty vector pJB908 (lanes 1 and 4), JV918 with the DotB
complementing clone pJB1153 (lanes 2 and 5), and JV918 with the
DotB K162Q clone pJB1568 (lanes 3 and 6). The molecular masses of
relevant markers (in kilodaltons) are on the left. (B) Total protein
(lanes 1 and 2) and total membrane protein (lanes 3 and 4) fractions
were taken from two E. coli strains and were used in DotB Western
blotting. Strains included XL1-Blue with the DotB complementing
clone pJB1153 (lanes 1 and 3) and XL1-Blue with the DotB K162Q
clone pJB1565 (lanes 2 and 4). (A and B) Large arrowhead, DotB;
small arrowhead, cross-reacting band that confirms overall sample
equivalence. The molecular masses of relevant markers (in kilodal-
tons) are on the left. Results are representative of several experiments.
FIG. 8. Nucleotide binding capacity of DotB and DotB K162Q.
(A) Coomassie-stained SDS-PAGE gel showing elution fractions from
DotB (lanes 1 to 3) and DotB K162Q (lanes 4 to 6) ATP binding
reactions. Purified protein was incubated with ATP-agarose (lanes 1
and 4), AMP-agarose (lanes 2 and 5), or ATP-agarose in the presence
of 10 mM competing free nucleotides (lanes 3 and 6), washed, and
eluted. The molecular masses of relevant markers (in kilodaltons) are
on the left. Large arrowhead, DotB; small arrowhead, BSA added to
reactions to prevent nonspecific binding. (B) Western blot of fractions
from binding reactions using L. pneumophila lysate containing wild-
type DotB (dotB strain JV918 with DotB complementing clone
pJB1153). Whole-cell lysate (lane 1) was incubated with ATP-agarose
(lanes 2 and 3), AMP-agarose (lanes 4 and 5), or ATP-agarose in the
presence of 10 mM competing free nucleotide (lanes 6 and 7), washed,
and eluted. Flowthrough (lanes 2, 4, and 6) and elution (lanes 3, 5, and
7) fractions were collected and subjected to DotB Western blotting.
(C) Western blot of fractions from binding reactions using L. pneu-
mophila lysate containing DotB K162Q (dotB strain JV918 with
DotB K162Q clone pJB1568). Whole-cell lysate (lane 1) was incubated
with ATP-agarose (lanes 2 and 3), AMP-agarose (lanes 4 and 5), or
ATP-agarose in the presence of 10 mM competing free nucleotides
(lanes 6 and 7), washed, and eluted. Flowthrough (lanes 2, 4, and 6)
and elution (lanes 3, 5, and 7) fractions were collected and subjected to
DotB Western blotting. The molecular masses of relevant markers (in
kilodaltons) are on the left.
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present in eluate from AMP-agarose, to which it should not
bind, or in eluate from ATP-agarose with competing free ATP
(Fig. 8A, compare lanes 1, 2, and 3). Likewise, DotB from L.
pneumophila lysate displayed the same pattern in the analo-
gous elution fractions (Fig. 8B, compare lanes 3, 5, and 7). In
contrast, DotB K162Q was not present in either ATP-agarose
elution fraction (Fig. 8A, lane 4, and C, lane 3), indicating that
it could not bind ATP either as a purified protein or when
present in L. pneumophila lysate. Thus, DotB K162Q cannot
bind ATP, a property which may help to explain its enhanced
membrane affinity.
DISCUSSION
We have purified the L. pneumophila DotB protein, shown
that it forms homohexameric rings, and demonstrated for the
first time that it exhibits ATPase activity. Moreover, ATPase
activity is critical to DotB function, since a Walker A box
mutant protein (DotB K162Q) that is deficient in ATP binding
and hydrolysis cannot complement a dotB strain for intracel-
lular growth. We have also observed that the dotBK162Q mu-
tation is dominant negative, likely due to the capacity of the
mutant protein to form mixed multimers with wild-type DotB.
Finally, we have demonstrated that the DotB K162Q protein
has enhanced membrane localization in L. pneumophila but
not in E. coli, suggesting the existence of a DotB-specific inner
membrane receptor.
The ATPase activity measured for DotB is equivalent to that
seen for several other secretion ATPases. R64 PilQ, Aquifex
aeolicus PilT, R388 TrwD, and Actinobacillus actinomycetem-
comitans TadA have similarly modest activities of between 1
and 15 nmol/min/mg (3, 10, 27, 29). Because this level of
activity appears to be inconsistent with the idea that type II and
type IV secretion ATPases are molecular motors, it has been
proposed that they may function as chaperones facilitating the
assembly or disassembly of secretion complexes and pili (10).
Alternatively, modest activity could be due to the absence of
stimulatory cofactors in ATPase reactions. For example, the
addition of phospholipids to purified H. pylori HP0525, RP4
TrbB, TrwD, and TadA increased their enzymatic activity 2- to
10-fold (3, 15, 27), suggesting that interactions with the cyto-
plasmic membrane may regulate their function.
To confirm the importance of DotB ATPase activity, we
constructed a mutant version of the protein which was enzy-
matically null and tested it for functionality in the context of L.
pneumophila intracellular growth. Similar to a strain lacking
DotB, a strain containing the DotB K162Q Walker A box
mutant protein in place of the wild-type protein was com-
pletely defective for growth inside macrophages. Thus, DotB
ATPase activity appears to be absolutely essential to its func-
tion in the Dot/Icm complex. Additionally, we observed that
the DotB K162Q protein inhibited the intracellular growth of
a wild-type L. pneumophila strain; this is the first description of
a dominant negative mutation in Legionella. The DotB K162Q
protein should prove to be a useful tool; potential applications
include selective inactivation of the Dot/Icm complex at vari-
ous stages of infection and inactivation of the DotB homologue in
C. burnetii. The latter would be especially useful because genetic
disruptions are not yet feasible in this system (33, 41, 42).
Other examples of secretion ATPase Walker A box muta-
tions that are dominant negative in character include
pilQK238Q and trwDK203Q (27, 29). In these cases, it was
proposed that dominance resulted from the formation of wild-
type and mutant mixed multimers; however, this remained
untested. Here we have successfully demonstrated that DotB
K162Q is capable of forming mixed multimers with wild-type
DotB in vivo, and this likely explains the dominant negative
phenotype of the dotBK162Q mutation. Consistent with this
idea, a model derived from several crystal structures of the H.
pylori type IVA secretion ATPase HP0525 proposes that the
ATPase cycles between at least three conformations via con-
certed changes that are likely to depend on the functionality of
all six subunits (31, 40). Thus, inactivation of even one subunit
may be sufficient to render the entire complex nonfunctional,
so that mixed multimers of functional and nonfunctional
monomers would exhibit a null phenotype.
In addition to its nonfunctional and dominant negative prop-
erties, the DotB K162Q mutant protein exhibited enhanced
membrane localization. Such augmented membrane localiza-
tion was likewise observed for the A. tumefaciens Walker box
VirB11 K175A mutant protein (25). Though the membrane
association of VirB11 does not require other VirB proteins
(25, 35), several type II secretion ATPases have been shown to
localize to the bacterial membrane only in the presence of
specific components of their respective secretion complexes (1,
24, 30). Because the DotB K162Q mutant protein displays
enhanced membrane localization only in the context of L.
pneumophila and not in E. coli, this suggests that there may be
an inner membrane receptor for DotB, perhaps another Dot/
Icm protein. Further characterization of DotB K162Q should
help to confirm the existence of such a receptor.
It is not clear what dictates the increased membrane local-
ization of the DotB and VirB11 Walker A box mutant proteins.
One possibility is that these proteins are locked in an altered
conformation that is more conducive to membrane association.
Experiments with PilQ have shown that it, like HP0525,
changes conformation upon ATP binding. Interestingly, when
a Walker A box mutant version of PilQ was examined, it was
found to exist only in what appeared to be the ATP-bound
conformation (29). To check DotB K162Q for an altered con-
formation, high-resolution electron microscopy comparing pu-
rified wild-type and mutant proteins was performed. We could
not detect gross conformational differences between them, ei-
ther in the presence or absence of nucleotides. Furthermore,
limited proteolysis failed to reveal any differences (data not
shown). In both cases, such changes may be too subtle to
detect. Regardless, it is clear that the mutant protein differs
from wild-type DotB in that it is no longer able to bind and
hydrolyze nucleotides.
Our work is in accordance with a model where secretion
ATPases cycle between cytoplasmic and membrane-linked
states by associating and disassociating with secretion com-
plexes at the inner membrane. While at the membrane, secre-
tion ATPases may function as gating molecules, cycling
through closed and open forms regulated by ATP binding and
hydrolysis. For DotB K162Q, its inability to bind and hydrolyze
nucleotides is likely to abolish this mode of action, leaving it
trapped in an intermediate step of normal DotB cycling at the
L. pneumophila membrane.
In this study, we have demonstrated that the L. pneumophila
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DotB protein has several characteristics in common with as-
sembly ATPases of type II and type IVA secretion systems and
with the retraction ATPase PilT: specifically, DotB is a hydro-
philic, membrane-associated ATPase that exists as a hexameric
ring, the enzymatic activity of which is critical to its function.
The significance of the intriguing homology between DotB and
the pilus retraction protein PilT remains to be determined, and
a potential role for DotB in pilus retraction awaits identifica-
tion of a putative Dot/Icm pilus. We have also demonstrated
here, based on observations of the mutant protein DotB
K162Q, that DotB hexamers likely need to hydrolyze ATP in a
concerted or rapidly successive fashion in order to function
effectively. These data will serve as the foundation for further
analysis of the DotB protein and should lead to a better un-
derstanding of its function on molecular and macromolecular
levels.
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